Dotatoc gallium Ga-68

Star0

DB18190InvestigationalSmall molecule

Dotatoc gallium Ga-68: Overview.

Mechanism: Pharmacologically active on Somatostatin receptor
Curator reviewed
Formula / weight: C₆₉H₉₁GaN₁₄O₁₇S₂ · 1520.62 g/mol (avg)
Also known as: (68ga)-dotanoc · 68-ga-dotanoc · Dota-nal3-octreotide Ga-68 · Dotanoc gallium Ga-68
Code names: DOTA-NOC GA-68

Resolves to

Compound

UNII8AHG0Z4Z5MCAS1040397-47-4

Structure

InChIKeyWLCSPWJAQXJSCS-LMLQMHQSSA-KSMILES

[68Ga+3].C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=CC3=CC=CC=C23)C(=O)N[C@H](CC2=CNC3=CC=CC=C23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which companies are running trials of Dotatoc gallium Ga-68, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account